Form 4: Alpha Cognition COO Awarded Equity & Options

Alpha Cognition Inc.'s Chief Operating Officer, Lauren D'Angelo, was granted 137,195 restricted stock units and 106,545 stock options, effective January 9, 2026.

Summary

• Lauren D'Angelo, Chief Operating Officer of Alpha Cognition Inc., was granted 137,195 common shares in the form of restricted stock units (RSUs).
• These RSUs will vest in three equal annual installments: 1/3 on January 9, 2027, 1/3 on January 9, 2028, and 1/3 on January 9, 2029.
• Additionally, D'Angelo was granted 106,545 common share options with an exercise price of $6.56.
• These options have an expiration date of January 9, 2036.
• The options will vest 1/3 on January 9, 2027, with the remaining portion vesting in equal quarterly installments thereafter.
• Both the RSUs and options were acquired at a price of $0, indicating they are compensation grants.
• The transactions are effective January 9, 2026, but the filing date is January 13, 2026, suggesting a pre-arranged compensation plan.

Sentiment

Score: 7

Explanation: The filing reports a standard executive compensation grant, which is generally positive for aligning management incentives with shareholder interests, but it does not contain new operational or financial performance data to significantly alter sentiment.

Positives

• The grant of restricted stock units and stock options aligns the Chief Operating Officer's interests with long-term shareholder value.
• The vesting schedules for both RSUs and options incentivize continued performance and retention of key management.

Future Outlook

The vesting schedules for the granted RSUs and options extend through January 9, 2029, and January 9, 2036, respectively, indicating a long-term incentive structure for the Chief Operating Officer.

Industry Context

This filing represents a standard executive compensation event, common across industries to align management incentives with long-term company performance and shareholder interests. It does not provide specific industry-related insights beyond this general context.

Comparison to Industry Standards

• The grant of equity compensation, including restricted stock units and stock options, is a common practice for executive compensation in publicly traded biotechnology and pharmaceutical companies, similar to peers like Biogen or Amgen, to incentivize long-term performance and retention.
• The vesting schedules, typically over several years, are standard for such grants, ensuring that executives remain committed to the company's strategic goals over an extended period.
• An exercise price for options set at the market price on the grant date (implied by the $0 acquisition price for the derivative itself) is also a standard practice for incentive stock options.

Related Party Transactions

• The transaction involves an executive (Lauren D'Angelo) and the company (Alpha Cognition Inc.), which is a related party transaction, but it is a standard compensation event disclosed as required by SEC regulations.

Stakeholder Impact

• Shareholders: The grants align the COO's interests with long-term shareholder value, potentially leading to better performance. Dilution from future share issuance upon vesting/exercise is a consideration, but this is standard for equity compensation.
• Employees: May signal stability in executive leadership and a commitment to long-term incentives.

Next Steps

• The restricted stock units will vest in three annual installments on January 9, 2027, January 9, 2028, and January 9, 2029.
• The common share options will begin vesting on January 9, 2027, with the remainder vesting quarterly thereafter until their expiration on January 9, 2036.

Key Dates

Recommendation

This Form 4 filing details a routine executive compensation grant and does not contain information that would fundamentally alter the investment thesis for Alpha Cognition Inc. While aligning executive incentives is a positive, it's an expected corporate action and not a catalyst for a 'buy' or 'sell' recommendation based solely on this filing. Investors should continue to hold and monitor the company's operational and financial performance.

Keywords

Alpha Cognition, ACOG, Lauren D'Angelo, Chief Operating Officer, COO, Restricted Stock Units, RSUs, Stock Options, Equity Grant, Executive Compensation, Insider Transaction, Form 4